New pharmacologic targets for the treatment of the overactive bladder: An updateANDERSSON, Karl-Erik.Urology (Ridgewood, NJ). 2004, Vol 63, Num 3A, pp 32-41, issn 0090-4295, 10 p., SUPConference Paper

The medical management of urinary incontinenceSHABAN, Ahmed; DRAKE, Marcus J; HASHIM, Hashim et al.Autonomic neuroscience : basic & clinical. 2010, Vol 152, Num 1-2, pp 4-10, issn 1566-0702, 7 p.Article

Anticholinergics for Overactive Bladder Therapy: Central Nervous System EffectsCHANCELLOR, Michael; BOONE, Timothy.CNS neuroscience & therapeutics (Print). 2012, Vol 18, Num 2, pp 167-174, issn 1755-5930, 8 p.Article

Measuring urgency in clinical practice : Update on Bladder Storage Disorders and the role of the symptom of urgencyDMOCHOWSKI, Roger R; FITZGERALD, Mary P; WYNDAELE, Jean-Jacques et al.World journal of urology (Print). 2009, Vol 27, Num 6, pp 739-745, issn 0724-4983, 7 p.Article

Overactive bladder syndrome : considerations in pharmacotherapy and new perspectivesSALVATORE, Stefano; SOLIGO, Marco; PROIETTI, Fabio et al.European journal of obstetrics, gynecology, and reproductive biology. 2005, Vol 120, Num 2, pp 129-133, issn 0301-2115, 5 p.Article

Overactive bladder: Diagnosis and managementROBINSON, Dudley; CARDOZO, Linda.Maturitas (Amsterdam). 2012, Vol 71, Num 2, pp 188-193, issn 0378-5122, 6 p.Article

Overactive bladder : the importance of new guidanceKIRBY, M; ARTIBANI, W; VAN KERREBROECK, P et al.International journal of clinical practice (Esher). 2006, Vol 60, Num 10, pp 1263-1271, issn 1368-5031, 9 p.Article

On the origins of the sensory output from the bladder : the concept of afferent noiseGILLESPIE, James I; VAN KOEVERINGE, Gommert A; DE WACHTER, Stefan G et al.BJU international (Papier). 2009, Vol 103, Num 10, pp 1324-1333, issn 1464-4096, 10 p.Article

Antimuscarinic agents : Implications and concerns in the management of overactive bladder in the elderlyKAY, Gary G; GRANVILLE, Lisa J.Clinical therapeutics. 2005, Vol 27, Num 1, pp 127-138, issn 0149-2918, 12 p.Article

Patient-reported reasons for discontinuing overactive bladder medicationBENNER, Joshua S; NICHOL, Michael B; ROVNER, Eric S et al.BJU international (Papier). 2010, Vol 105, Num 9, pp 1276-1282, issn 1464-4096, 7 p.Article

Psychometric evaluation of the medical outcomes study-sleep scale in persons with overactive bladderLAU, Denys T; MORLOCK, Robert J; HILL, Cheryl D et al.Clinical therapeutics. 2006, Vol 28, Num 12, pp 2119-2132, issn 0149-2918, 14 p.Article

Overactive bladder : Treatment options for the aging womanSUN HEE PARK; DAVILA, G. Willy.International journal of fertility and women's medicine. 2005, Vol 50, Num 1, pp 37-44, issn 1534-892X, 8 p.Article

Psychometric assessment of female overactive bladder syndrome and antimuscarinics-related effectsHSIAO, Sheng-Mou; LIAO, Shih-Cheng; CHEN, Chi-Hau et al.Maturitas (Amsterdam). 2014, Vol 79, Num 4, pp 428-434, issn 0378-5122, 7 p.Article

The management of overactive bladder refractory to medical therapyROBINSON, Dudley; GIARENIS, Ilias; CARDOZO, Linda et al.Maturitas (Amsterdam). 2013, Vol 75, Num 1, pp 101-104, issn 0378-5122, 4 p.Article

New developments in the medical management of overactive bladderROBINSON, Dudley; GIARENIS, Ilias; CARDOZO, Linda et al.Maturitas (Amsterdam). 2013, Vol 76, Num 3, pp 225-229, issn 0378-5122, 5 p.Article

Maximal functional electrical stimulation as a single treatment : Is it cost-effective?FEHRLING, Marianne; FALL, Magnus; PEEKER, Ralph et al.Scandinavian journal of urology and nephrology. 2007, Vol 41, Num 2, pp 132-137, issn 0036-5599, 6 p.Article

The validation of the patient perception of bladder condition (PPBC) : A single-item global measure for patients with overactive bladderCOYNE, Karin S; MATZA, Louis S; KOPP, Zoe et al.European urology. 2006, Vol 49, Num 6, pp 1079-1086, issn 0302-2838, 8 p.Article

The pharmacokinetic profile of fesoterodine 8 mg with daytime or nighttime dosingMALHOTRA, Bimal K; CROWNOVER, Penelope H; LABADIE, Robert et al.European journal of clinical pharmacology. 2010, Vol 66, Num 2, pp 171-176, issn 0031-6970, 6 p.Article

A pilot study of Connexin 43 (Cx43) in human bladder tissue in patients with idiopathic detrusor overactivityKUHN, Annette; STADLMAYR, Werner; MONGA, Ash et al.European journal of obstetrics, gynecology, and reproductive biology. 2008, Vol 141, Num 1, pp 83-86, issn 0301-2115, 4 p.Article

Estimated Cost of Overactive Bladder in ThailandPRASOPSANTI, Kriangsak; SANTI-NGAMKUN, Apirak; PORNPRASITMD, Kanokwan et al.Chot Mai Het Thang Phaet. 2007, Vol 90, Num 11, pp 2316-2320, issn 0125-2208, 5 p.Article

Overactive bladder : Prevalence and implications in BrazilTELOKEN, Claudio; CARAVER, Fernanda; WEBER, Fernanda A et al.European urology. 2006, Vol 49, Num 6, pp 1087-1092, issn 0302-2838, 6 p.Article

Solifenacin is effective for thetreatment of OAB dry patients : A pooled analysisABRAMS, Paul; SWIFT, Steven.European urology. 2005, Vol 48, Num 3, pp 483-487, issn 0302-2838, 5 p.Article

Overactive bladderHENDERSON, Emily; DRAKE, Marcus.Maturitas (Amsterdam). 2010, Vol 66, Num 3, pp 257-262, issn 0378-5122, 6 p.Article

Botulinum toxin injections for neurogenic and idiopathic detrusor overactivity : A critical analysis of resultsPATEL, Anand K; PATTERSON, Jacob M; CHAPPLE, Christopher R et al.European urology. 2006, Vol 50, Num 4, pp 684-710, issn 0302-2838, 27 p.Article

Efficacy and Adverse Events of Antimuscarinics for Treating Overactive Bladder: Network Meta-analysesBUSER, Nora; IVIC, Sandra; KESSLER, Thomas M et al.European urology. 2012, Vol 62, Num 6, pp 1040-1060, issn 0302-2838, 21 p.Article